BLUJEPA FDA approval date

The FDA approved BLUJEPA on 25 Mar 2025.

FDA approval date
25 Mar 2025

Drug identity has not yet been verified against registry records

Also recorded as GEPOTIDACIN MESYLATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-03-25DayBLUJEPAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218230", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE", "brand_names": ["BLUJEPA"], "active_ingredients": ["GEPOTIDACIN MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250325", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026